{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:18:27Z","timestamp":1778494707828,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.044","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T17:33:28Z","timestamp":1551202408000},"page":"1928-1937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-2027","authenticated-orcid":false,"given":"Jes\u00fas","family":"Zepeda-Cervantes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-3204","authenticated-orcid":false,"given":"Adolfo","family":"Cruz-Res\u00e9ndiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Sampieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalba","family":"Carre\u00f3n-N\u00e1poles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Iv\u00e1n","family":"S\u00e1nchez-Betancourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2266-4847","authenticated-orcid":false,"given":"Luis","family":"Vaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.044_b0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/295064a0","article-title":"A very small porcine virus with circular single-stranded DNA","volume":"295","author":"Tischer","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.02.044_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tvjl.2010.01.018","article-title":"Recent advances in the epidemiology, diagnosis and control of diseases caused by Porcine Circovirus Type 2","volume":"187","author":"Grau-Roma","year":"2011","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2019.02.044_b0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1079\/AHR2005106","article-title":"Porcine circovirus diseases","volume":"6","author":"Segal\u00e9s","year":"2005","journal-title":"Anim Heal Res Rev"},{"key":"10.1016\/j.vaccine.2019.02.044_b0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tvjl.2012.06.031","article-title":"Commercial Porcine Circovirus Type 2 vaccines: efficacy and clinical application","volume":"194","author":"Chae","year":"2012","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2019.02.044_b0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11259-008-9080-8","article-title":"A DNA miniarray system for simultaneous visual detection of Porcine Circovirus Type 1 (PCV1) and 2 (PCV2) in pigs","volume":"33","author":"An","year":"2009","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2019.02.044_b0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vetmic.2003.10.006","article-title":"Pathological findings associated with naturally acquired Porcine Circovirus Type 2 associated disease","volume":"98","author":"Segal\u00e9s","year":"2004","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tvjl.2004.01.012","article-title":"A review of porcine circovirus 2-associated syndromes and diseases","volume":"169","author":"Chae","year":"2005","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2019.02.044_b0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2011.10.007","article-title":"Porcine Circovirus Type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis","volume":"164","author":"Segal\u00e9s","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.02.044_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2008.09.005","article-title":"Porcine circovirus 2 infection of epithelial cells is clathrin-, caveolae- and dynamin-independent, actin and Rho-GTPase-mediated, and enhanced by cholesterol depletion","volume":"139","author":"Misinzo","year":"2009","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.02.044_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virusres.2011.11.003","article-title":"Cell tropism and entry of porcine circovirus 2","volume":"164","author":"Nauwynck","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.02.044_b0055","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1099\/0022-1317-81-9-2281","article-title":"Open reading frame 2 of Porcine Circovirus Type 2 encodes a major capsid protein","volume":"81","author":"Nawagitgul","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0060","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JVI.80.7.3487-3494.2006","article-title":"Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells","volume":"80","author":"Misinzo","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0065","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/S0264-410X(03)00503-6","article-title":"Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by Porcine Circovirus Type 2 (PCV2) proteins","volume":"21","author":"Blanchard","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.044_b0070","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/tbed.12714","article-title":"Detection and genetic characterization of Porcine Circovirus Type 3 in Italy","volume":"64","author":"Faccini","year":"2017","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2019.02.044_b0075","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/tbed.12638","article-title":"Identification and genetic characterization of Porcine Circovirus Type 3 in China","volume":"64","author":"Ku","year":"2017","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2019.02.044_b0080","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/tbed.12672","article-title":"First detection of Porcine Circovirus Type 3 on commercial pig farms in Poland","volume":"64","author":"Stadejek","year":"2017","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2019.02.044_b0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2016.10.002","article-title":"Ten years of PCV2 vaccines and vaccination: is eradication a possibility?","volume":"206","author":"Afghah","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v9050099","article-title":"Porcine Circovirus Type 2 (PCV2) vaccines in the context of current molecular epidemiology","volume":"9","author":"Karuppannan","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2019.02.044_b0095","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.vaccine.2009.07.061","article-title":"The optimized capsid gene of Porcine Circovirus Type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts","volume":"27","author":"Bucarey","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.044_b0100","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jip.2011.05.004","article-title":"Large-scale production and purification of VLP-based vaccines","volume":"107","author":"Vicente","year":"2011","journal-title":"J Invertebr Pathol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.044_b0110","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/elps.200900558","article-title":"Separation and quantification of double- and triple-layered rotavirus-like particles by CZE","volume":"31","author":"Castro-Acosta","year":"2010","journal-title":"Electrophoresis"},{"key":"10.1016\/j.vaccine.2019.02.044_b0115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/biot.201400427","article-title":"Enveloped virus-like particles as vaccines against pathogenic arboviruses","volume":"10","author":"Pijlman","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2019.02.044_b0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-3527(06)68005-6","article-title":"Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce \u201cmammalianized\u201d recombinant glycoproteins","volume":"68","author":"Harrison","year":"2006","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2019.02.044_b0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetmic.2015.02.027","article-title":"Comparison of three commercial one-dose Porcine Circovirus Type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b","volume":"177","author":"Jeong","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.prevetmed.2010.11.015","article-title":"A meta-analysis comparing the effect of PCV2 vaccines on average daily weight gain and mortality rate in pigs from weaning to slaughter","volume":"98","author":"Kristensen","year":"2011","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2019.02.044_b0135","first-page":"S103","article-title":"Downstream processing of viral vectors and vaccines","volume":"12","author":"Morenweiser","year":"2005","journal-title":"GeneTher"},{"key":"10.1016\/j.vaccine.2019.02.044_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12858-015-0034-9","article-title":"Identification of fragments from Autographa Californica polyhedrin protein essential for self-aggregation and exogenous protein incorporation","volume":"16","author":"Sampieri","year":"2015","journal-title":"BMC Biochem"},{"key":"10.1016\/j.vaccine.2019.02.044_b0145","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2018.1507742","article-title":"Induction of adaptive immune response by self-aggregating peptides","author":"Zepeda-Cervantes","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.02.044_b0150","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.5897\/AJB11.2848","article-title":"Stability of Spodoptera litura nucleopolyhedrovirus in sodium dodecyl sulphate","volume":"11","author":"Nazli-Huda","year":"2012","journal-title":"African J Biotechnol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0155","first-page":"119","article-title":"Generation of antibodies specific to d-mannitol, a unique haptenic allergen, using reductively aminated d-mannose-bovine serum albumin conjugate as the immunogen","volume":"2012","author":"Hedge","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.02.044_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep39458","article-title":"Porcine Circovirus Type 2 (PCV2) evolution before and after the vaccination introduction: a large scale epidemiological study","volume":"6","author":"Franzo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.02.044_b0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-3527(06)69003-9","article-title":"The baculoviruses occlusion-derived virus: virion structure and function","volume":"69","author":"Slack","year":"2006","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2019.02.044_b0170","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0175","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1016\/j.xphs.2016.08.009","article-title":"A comprehensive evaluation of nanoparticle tracking analysis (nanosight) for characterization of proteinaceous submicron particles","volume":"105","author":"Tian","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2019.02.044_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0168939","article-title":"Two distinctive phenotypes of AcMNPV display different immune abilities and intracellular destiny","volume":"11","author":"Molina","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.02.044_b0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12033-011-9431-5","article-title":"Production of classical swine fever virus envelope glycoprotein E2 as recombinant polyhedra in baculovirus-infected silkworm larvae","volume":"50","author":"Lee","year":"2012","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0190","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1128\/jvi.71.10.7207-7213.1997","article-title":"Expression and self-assembly of empty virus-like particles of hepatitis E virus","volume":"71","author":"Li","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/prep.1999.1155","article-title":"Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae","volume":"17","author":"Cook","year":"1999","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2019.02.044_b0200","doi-asserted-by":"crossref","unstructured":"Chung Y, Huang J, Lai C, Sheng H, Shih S, Ho M, et al. Expression, purification and characterization of enterovirus-71 virus-like particles 2006;12:921\u20137.","DOI":"10.3748\/wjg.v12.i6.921"},{"key":"10.1016\/j.vaccine.2019.02.044_b0205","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.1016\/j.biomaterials.2013.07.063","article-title":"The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation","volume":"34","author":"Chen","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2019.02.044_b0210","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1073\/pnas.0912124107","article-title":"A self-assembling peptide acting as an immune adjuvant","volume":"107","author":"Rudra","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2019.02.044_b0215","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1016\/j.biomaterials.2012.05.041","article-title":"Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope","volume":"33","author":"Rudra","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2019.02.044_b0220","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.vaccine.2013.11.047","article-title":"Antigenic peptide nanofibers elicit adjuvant-free CD8+ T cell responses","volume":"32","author":"Chesson","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.044_b0225","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1016\/j.biomaterials.2010.07.068","article-title":"Immune responses to coiled coil supramolecular biomaterials","volume":"31","author":"Rudra","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2019.02.044_b0230","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1208\/s12248-014-9707-3","article-title":"Peptide amphiphile micelles self-adjuvant group A streptococcal vaccination","volume":"17","author":"Trent","year":"2015","journal-title":"AAPS J"},{"key":"10.1016\/j.vaccine.2019.02.044_b0235","doi-asserted-by":"crossref","first-page":"15948","DOI":"10.1039\/C4CC07511K","article-title":"Toll-like receptor agonist lipopeptides self-assemble into distinct nanostructures","volume":"50","author":"Hamley","year":"2014","journal-title":"Chem Commun"},{"key":"10.1016\/j.vaccine.2019.02.044_b0240","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1039\/C4OB00447G","article-title":"Self-assembly of peptides to nanostructures","volume":"12","author":"Mandal","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.vaccine.2019.02.044_b0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1051\/vetres:2003039","article-title":"Lack of an effect of a commercial vaccine adjuvant on the development of postweaning multisystemic wasting syndrome (PMWS) in Porcine Circovirus Type 2 (PCV2) experimentally infected conventional pigs","volume":"35","author":"Resendes","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2019.02.044_b0250","first-page":"716","article-title":"Mycoplasma hyopneumoniae bacterins and Porcine Circovirus Type 2 (PCV2) infection: Induction of postweaning multisystemic wasting syndrome (PMWS) in the gnotobiotic swine model of PCV2-associated disease","volume":"48","author":"Krakowka","year":"2007","journal-title":"Can Vet J"},{"key":"10.1016\/j.vaccine.2019.02.044_b0255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.vetmic.2007.06.004","article-title":"Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs","volume":"125","author":"Fort","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.02.044_b0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-animal-031412-103720","article-title":"Porcine Circovirus Type 2 (PCV2): pathogenesis and interaction with the immune system","volume":"1","author":"Meng","year":"2013","journal-title":"Annu Rev Anim Biosci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:31:09Z","timestamp":1759401069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":52,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19302518"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}